APA (7th ed.) Citation

LK, C., C, D., P, T., KE, E., A, A., F, D., . . . C, S. (2025). Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells. International journal of molecular sciences, 26(13), . https://doi.org/10.3390/ijms26136506

Chicago Style (17th ed.) Citation

LK, Cabral, Disoma C, Tarchi P, El-Khobar KE, Agustiningsih A, Dituri F, Tiribelli C, and Sukowati C. "Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells." International Journal of Molecular Sciences 26, no. 13 (2025). https://doi.org/10.3390/ijms26136506.

MLA (9th ed.) Citation

LK, Cabral, et al. "Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells." International Journal of Molecular Sciences, vol. 26, no. 13, 2025, https://doi.org/10.3390/ijms26136506.